Literature DB >> 17072309

Molecular ablation of ventricular tachycardia after myocardial infarction.

Tetsuo Sasano1, Amy D McDonald, Kan Kikuchi, J Kevin Donahue.   

Abstract

Ventricular tachycardia is a common and lethal complication after myocardial infarction. Here we show that focal transfer of a gene encoding a dominant-negative version of the KCNH2 potassium channel (KCNH2-G628S) to the infarct scar border eliminated all ventricular arrhythmias in a porcine model. No proarrhythmia or other negative effects were discernable. Our results demonstrate the potential viability of gene therapy for ablation of ventricular arrhythmias.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17072309      PMCID: PMC1783685          DOI: 10.1038/nm1503

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  12 in total

1.  Complications associated with implantable cardioverter-defibrillator replacement in response to device advisories.

Authors:  Paul A Gould; Andrew D Krahn
Journal:  JAMA       Date:  2006-04-26       Impact factor: 56.272

2.  Biological pacemaker created by gene transfer.

Authors:  Junichiro Miake; Eduardo Marbán; H Bradley Nuss
Journal:  Nature       Date:  2002-09-12       Impact factor: 49.962

3.  Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors.

Authors:  R O Snyder; C H Miao; G A Patijn; S K Spratt; O Danos; D Nagy; A M Gown; B Winther; L Meuse; L K Cohen; A R Thompson; M A Kay
Journal:  Nat Genet       Date:  1997-07       Impact factor: 38.330

4.  Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors.

Authors:  T Kafri; U Blömer; D A Peterson; F H Gage; I M Verma
Journal:  Nat Genet       Date:  1997-11       Impact factor: 38.330

5.  Cellular uncoupling can unmask dispersion of action potential duration in ventricular myocardium. A computer modeling study.

Authors:  M D Lesh; M Pring; J F Spear
Journal:  Circ Res       Date:  1989-11       Impact factor: 17.367

6.  Focal modification of electrical conduction in the heart by viral gene transfer.

Authors:  J K Donahue; A W Heldman; H Fraser; A D McDonald; J M Miller; J J Rade; T Eschenhagen; E Marbán
Journal:  Nat Med       Date:  2000-12       Impact factor: 53.440

7.  Radiofrequency catheter ablation of postinfarction ventricular tachycardia: long-term success and the significance of inducible nonclinical arrhythmias.

Authors:  S A Rothman; H H Hsia; S F Cossú; I L Chmielewski; A E Buxton; J M Miller
Journal:  Circulation       Date:  1997-11-18       Impact factor: 29.690

8.  Expression and function of a biological pacemaker in canine heart.

Authors:  Jihong Qu; Alexei N Plotnikov; Peter Danilo; Iryna Shlapakova; Ira S Cohen; Richard B Robinson; Michael R Rosen
Journal:  Circulation       Date:  2003-03-04       Impact factor: 29.690

9.  Avoidance of immune response prolongs expression of genes delivered to the adult rat myocardium by replication-defective adenovirus.

Authors:  M J Quiñones; J Leor; R A Kloner; M Ito; M Patterson; W F Witke; L Kedes
Journal:  Circulation       Date:  1996-09-15       Impact factor: 29.690

10.  In vivo gene transfer of Kv1.5 normalizes action potential duration and shortens QT interval in mice with long QT phenotype.

Authors:  Michael Brunner; Sodikdjon A Kodirov; Gary F Mitchell; Peter D Buckett; Katsushi Shibata; Eduardo J Folco; Linda Baker; Guy Salama; Danny P Chan; Jun Zhou; Gideon Koren
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-07       Impact factor: 4.733

View more
  52 in total

Review 1.  Regenerative therapies in electrophysiology and pacing: introducing the next steps.

Authors:  Gerard J J Boink; Michael R Rosen
Journal:  J Interv Card Electrophysiol       Date:  2010-12-16       Impact factor: 1.900

2.  Effect of skeletal muscle Na(+) channel delivered via a cell platform on cardiac conduction and arrhythmia induction.

Authors:  Gerard J J Boink; Jia Lu; Helen E Driessen; Lian Duan; Eugene A Sosunov; Evgeny P Anyukhovsky; Iryna N Shlapakova; David H Lau; Tove S Rosen; Peter Danilo; Zhiheng Jia; Nazira Ozgen; Yevgeniy Bobkov; Yuanjian Guo; Peter R Brink; Yelena Kryukova; Richard B Robinson; Emilia Entcheva; Ira S Cohen; Michael R Rosen
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-06-21

Review 3.  Gene therapy for ventricular tachyarrhythmias.

Authors:  J K Donahue
Journal:  Gene Ther       Date:  2012-04-26       Impact factor: 5.250

4.  Selective molecular potassium channel blockade prevents atrial fibrillation.

Authors:  Guy Amit; Kan Kikuchi; Ian D Greener; Lizhu Yang; Victor Novack; J Kevin Donahue
Journal:  Circulation       Date:  2010-05-17       Impact factor: 29.690

Review 5.  Stem cells in the heart: what's the buzz all about?--Part 1: preclinical considerations.

Authors:  Rachel Ruckdeschel Smith; Lucio Barile; Elisa Messina; Eduardo Marbán
Journal:  Heart Rhythm       Date:  2008-02-15       Impact factor: 6.343

Review 6.  Regenerative therapies in electrophysiology and pacing.

Authors:  Michael R Rosen; Peter R Brink; Ira S Cohen; Peter Danilo; Richard B Robinson; Amy B Rosen; Matthias J Szabolcs
Journal:  J Interv Card Electrophysiol       Date:  2008-03-25       Impact factor: 1.900

Review 7.  Gene therapies for arrhythmias in heart failure.

Authors:  Fadi G Akar; Roger J Hajjar
Journal:  Pflugers Arch       Date:  2014-02-26       Impact factor: 3.657

8.  Gene therapy approaches to ventricular tachyarrhythmias.

Authors:  J Kevin Donahue; Tetsuo Sasano; Kamilla Kelemen
Journal:  J Electrocardiol       Date:  2007 Nov-Dec       Impact factor: 1.438

Review 9.  Making better scar: Emerging approaches for modifying mechanical and electrical properties following infarction and ablation.

Authors:  Jeffrey W Holmes; Zachary Laksman; Lior Gepstein
Journal:  Prog Biophys Mol Biol       Date:  2015-11-23       Impact factor: 3.667

10.  Molecular mechanisms of inherited arrhythmias.

Authors:  Cordula M Wolf; Charles I Berul
Journal:  Curr Genomics       Date:  2008-05       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.